InMed Pharmaceuticals Inc. (INM)
Develops prescription drugs and manufacturing technology based on cannabinoids for skin and brain diseases.
$1.67+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-30.1%
The outlook
INM is trading at $1.67, positioned above both its 50- and 200-day moving averages, which reflects an upward technical trend. The stock sits near the midpoint of its 52-week range. Analyst coverage appears thin, so detailed rating and target data aren't available to assess consensus opinion.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range52% of the way from its 52-week low to high
Market cap
$8.9M
52-wk high
$2.70
52-wk low
$0.58
50-day avg
$1.53
200-day avg
$1.25
Trailing P/E
—